Reminder - Goldcorp Inc (GG) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 10/15/13, Goldcorp Inc (GG) will trade ex-dividend, for its monthly dividend of $0.05, payable on 10/25/13. As a percentage of GG's recent stock price of $23.84, this dividend works out to approximately 0.21%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for GG, showing historical dividends prior to the most recent $0.05 declared by Goldcorp Inc:

GG+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from GG is likely to continue, and whether the current estimated yield of 2.52% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of GG shares, versus its 200 day moving average:

Goldcorp Inc 200 Day Moving Average Chart

Looking at the chart above, GG's low point in its 52 week range is $22.22 per share, with $45.53 as the 52 week high point — that compares with a last trade of $23.85.
Three Months Free, a $100 Value, Just Submit Your Top Stock Pick! (Offer ends 11/10/2013)

According to the ETF Finder at ETF Channel, GG makes up 11.80% of the Gold Miners ETF ( GDX) which is trading lower by about 1.3% on the day Friday.

In Friday trading, Goldcorp Inc shares are currently off about 1.8% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says